TGM2 and breast carcinoma: Corroborating this finding, He et al. demonstrated that inhibition of TTG by shRNA results in the downregulation of EMT via an increase of E-cadherin expression and a decrease of vimentin expression in MDA-MB-231 breast cancer cells.